Establishing a predictive nomogram for 21‑day transplant-free survival in drug-induced liver failure
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new nomogram accurately predicts transplant-free survival in drug-induced liver failure (DILF) patients using simple clinical data. This tool aids in better patient management and prognosis assessment for DILF.
Area Of Science
- Hepatology
- Clinical Medicine
- Predictive Analytics
Background
- Drug-induced liver failure (DILF) presents a significant clinical challenge due to its high prevalence.
- Accurate prognostication is crucial for timely intervention and management of DILF patients.
Purpose Of The Study
- To identify key clinical features of DILF.
- To develop a user-friendly nomogram for predicting transplant-free survival (TFS) in DILF patients.
- To assess the nomogram's predictive accuracy compared to existing models.
Main Methods
- A cohort of 202 DILF patients was analyzed.
- Clinical data was collected, and Cox regression identified independent risk factors for mortality or liver transplantation.
- A predictive nomogram was constructed using identified risk factors.
Main Results
- Neutrophils, prothrombin time, albumin, acute kidney injury, and hepatic encephalopathy were identified as independent risk factors.
- The developed nomogram demonstrated high predictive accuracy with an AUC of 0.947 for 21-day TFS.
- The nomogram incorporates easily measurable clinical and laboratory metrics.
Conclusions
- The novel nomogram provides a more accurate and accessible tool for predicting TFS in DILF patients.
- It surpasses existing models like the Model for End-Stage Liver Disease score in predictive capability.
- The nomogram facilitates direct calculation of TFS at various time points, aiding clinical decision-making.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
